A fibrous layer, wherein surface of the fibres has surface energy below 50 mN/m, characterised in that the calculated strike through time coefficient (cSTT) of the fibrous layer is below 20 and the fibrous layer is bonded in its entire volume at fibre to fibre contact bonding points, wherein the specific fibre surface is the surface area of the fibres in m.sup.2 per 1 m.sup.2 of the fibrous layer, basis weight is the weight of the layer in kg per 1 m.sup.2 of the fibrous layer, the specific void volume is the volume of empty spaces between the fibres in m.sup.3 per 1 m.sup.2 of the fibrous layer.

[00001]$\mathrm{cSTT}=\frac{{\left(\mathrm{specific}\mathrm{fibre}\mathrm{surface}\right)}^2\times \left(\mathrm{basis}\mathrm{weight}\right)}{\left(\mathrm{specific}\mathrm{void}\mathrm{volume}\right)\times {\left(\mathrm{surface}\mathrm{energy}\mathrm{of}\mathrm{fibre}\mathrm{surface}\right)}^3}\times 600$

A fibrous layer, wherein surface of the fibres has surface energy below 50 mN/m, characterised in that the calculated strike through time coefficient (cSTT) of the fibrous layer is below 20 and the fibrous layer is bonded in its entire volume at fibre to fibre contact bonding points, wherein the specific fibre surface is the surface area of the fibres in m.sup.2 per 1 m.sup.2 of the fibrous layer, basis weight is the weight of the layer in kg per 1 m.sup.2 of the fibrous layer, the specific void volume is the volume of empty spaces between the fibres in m.sup.3 per 1 m.sup.2 of the fibrous layer.

[00001]$\mathrm{cSTT}=\frac{{\left(\mathrm{specific}\mathrm{fibre}\mathrm{surface}\right)}^2\times \left(\mathrm{basis}\mathrm{weight}\right)}{\left(\mathrm{specific}\mathrm{void}\mathrm{volume}\right)\times {\left(\mathrm{surface}\mathrm{energy}\mathrm{of}\mathrm{fibre}\mathrm{surface}\right)}^3}\times 600$

The present invention relates to nanofibrillar polysaccharide hydrogels for use in the prevention and control of scarring and contraction in connection with wound healing or tissue repair.

The present invention relates to nanofibrillar polysaccharide hydrogels for use in the prevention and control of scarring and contraction in connection with wound healing or tissue repair.

A substrate based skin contact material formed from a hydrocolloid having a silicone based component extending over regions of the substrate surface. The adhesive is formed non-continuously over the substrate to provide areas devoid of adhesive to allow appreciable moisture transfer between the skin and substrate and improve the skin friendliness of the material during use and allow convenient removal with avoidance of skin irritation.

A substrate based skin contact material formed from a hydrocolloid having a silicone based component extending over regions of the substrate surface. The adhesive is formed non-continuously over the substrate to provide areas devoid of adhesive to allow appreciable moisture transfer between the skin and substrate and improve the skin friendliness of the material during use and allow convenient removal with avoidance of skin irritation.

An article. The article includes a substrate, wherein the substrate having two opposing major surfaces; and particles coated with a metal oxide on the substrate: particles coated with a metal on the substrate; wherein the coated particles are randomly distributed on or in the substrate; and wherein at least some of coated particles are discrete particles.

An article. The article includes a substrate, wherein the substrate having two opposing major surfaces; and particles coated with a metal oxide on the substrate: particles coated with a metal on the substrate; wherein the coated particles are randomly distributed on or in the substrate; and wherein at least some of coated particles are discrete particles.

The invention provides a wound dressing made by an ex vivo formed combination of fibrinogen and/or fibrin containing-liquid formulation and an oxidized cellulose (OC) backing; and use thereof.

The invention provides a wound dressing made by an ex vivo formed combination of fibrinogen and/or fibrin containing-liquid formulation and an oxidized cellulose (OC) backing; and use thereof.